Statements (14)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
synthetic cannabinoid
|
| gptkbp:agonist_of |
gptkb:CB1_receptor
gptkb:CB2_receptor |
| gptkbp:CASNumber |
131543-23-2
|
| gptkbp:chemicalFormula |
C27H27NO3
|
| gptkbp:developedBy |
gptkb:Sterling_Winthrop
|
| https://www.w3.org/2000/01/rdf-schema#label |
WIN 55,212-3
|
| gptkbp:IUPACName |
(R)-(+)-[2,3-Dihydro-5-methyl-3-(4-morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1-naphthalenylmethanone
|
| gptkbp:legalStatus |
controlled substance in some countries
|
| gptkbp:molecularWeight |
413.51 g/mol
|
| gptkbp:relatedTo |
cannabinoid receptor
|
| gptkbp:used_in |
scientific research
|
| gptkbp:bfsParent |
gptkb:WIN_55,212-2
|
| gptkbp:bfsLayer |
8
|